ELEVEN BIOTHERAPEUTICS INC - COM (EBIO)

CUSIP: 286221106

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
1,241,792
Share change
+176,065
Total reported value
$1,947,000
Price per share
$1.57
Number of holders
20
Value change
+$167,121
Number of buys
11
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q2 2017

As of 30 Jun 2017, ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,241,792 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Virtu KCG Holdings LLC, Spark Investment Management LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, A.R.T. Advisors, LLC, Bank of New York Mellon Corp, and PANAGORA ASSET MANAGEMENT INC. This page lists 20 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.